Since HIV transmission appears to be mostly associated with R5 HIV-1 regardless of subtype [46-48] and a large majority of chronic HIV-1 infections in India and South Africa are R5, CCR5 antagonists may have a role in prevention efforts: for example, use as microbicides or in pre- and post-exposure prophylaxis. This evidence concerns the gene CCR5 and HIV-1 infection.